ATE174932T1 - Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen - Google Patents

Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE174932T1
ATE174932T1 AT92118271T AT92118271T ATE174932T1 AT E174932 T1 ATE174932 T1 AT E174932T1 AT 92118271 T AT92118271 T AT 92118271T AT 92118271 T AT92118271 T AT 92118271T AT E174932 T1 ATE174932 T1 AT E174932T1
Authority
AT
Austria
Prior art keywords
compositions containing
vip
modified
pharmaceutical compositions
fragments
Prior art date
Application number
AT92118271T
Other languages
English (en)
Inventor
Illana Gozes
Matityahu Fridkin
Original Assignee
Yeda Res & Dev
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Univ Ramot filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE174932T1 publication Critical patent/ATE174932T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57563Vasoactive intestinal peptide [VIP]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92118271T 1991-10-31 1992-10-26 Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen ATE174932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL9992491A IL99924A (en) 1991-10-31 1991-10-31 Derivatives of structurally modified vip and pharmaceutical compositions containing them
CN93101710A CN1060178C (zh) 1991-10-31 1993-01-15 新的结构改性的活性肠肽衍生物、其药物组合物及其治疗男性阳痿的应用

Publications (1)

Publication Number Publication Date
ATE174932T1 true ATE174932T1 (de) 1999-01-15

Family

ID=36792814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92118271T ATE174932T1 (de) 1991-10-31 1992-10-26 Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen

Country Status (7)

Country Link
EP (1) EP0540969B1 (de)
JP (1) JP3311800B2 (de)
KR (1) KR100240434B1 (de)
CN (1) CN1060178C (de)
AT (1) ATE174932T1 (de)
DE (1) DE69227979T2 (de)
IL (1) IL99924A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447912A (en) * 1989-09-18 1995-09-05 Senetek, Plc Erection-inducing methods and compositions
IL105061A (en) * 1993-03-16 2000-11-21 Yeda Res & Dev Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
US5565424A (en) * 1994-02-07 1996-10-15 Ramot - University Authority For Applied Research And Industrial Development Ltd. Superactive VIP antagonists
IL118003A0 (en) * 1996-04-23 1996-08-04 Yeda Res & Dev Novel vip fragments and pharmaceutical compositions comprising them
IL136631A0 (en) * 2000-06-07 2001-06-14 Yeda Res & Dev Vip-related peptides for treatment of skin disordes
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8178495B2 (en) 2008-06-27 2012-05-15 Duke University Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605641A (en) * 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
SE8702520D0 (sv) * 1987-06-16 1987-06-16 Kabigen Ab Mammal intestine hormone precursor
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
DK0463450T3 (da) * 1990-06-26 1994-06-27 Sanwa Kagaku Kenkyusho Co Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf

Also Published As

Publication number Publication date
IL99924A0 (en) 1992-08-18
CN1060178C (zh) 2001-01-03
EP0540969A3 (de) 1994-08-03
KR100240434B1 (ko) 2000-01-15
DE69227979T2 (de) 1999-07-01
IL99924A (en) 1995-12-31
DE69227979D1 (de) 1999-02-04
JPH06206898A (ja) 1994-07-26
JP3311800B2 (ja) 2002-08-05
CN1089950A (zh) 1994-07-27
EP0540969A2 (de) 1993-05-12
EP0540969B1 (de) 1998-12-23

Similar Documents

Publication Publication Date Title
FI860153A0 (fi) Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning.
DK0929574T3 (da) Modulatorer af beta-amyloidpeptidaggregering, som omfatter D-aminosyrer
RU94046251A (ru) Глюкагоноподобный пептид и производные инсулино-тропина, способ получений, фармацевтические композиции, способы лечения диабета
DK197186A (da) Fluorescerende mono-, di- eller polyamider af en aminomonocarboxylsyre og en tetrapyrrol indeholdende mindst tre carboxylgrupper
DK0792287T3 (da) Peptidanaloger af humant basisk myelinprotein
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
ES2071815T3 (es) Analogos de delecion de los peptidos conocidos como magaininas.
ATE174932T1 (de) Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen
DE59010316D1 (de) Neue Insulinderivate, Verfahren zu deren Herstellung, ihre Verwendung und eine sie enthaltende pharmazeutische Zubereitung
GR880300151T1 (en) Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
ES2169037T3 (es) Conjugados polietilenglicol-hirudina, su procedimiento de preparacion y su empleo para el tratamiento de las trombosis.
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
ATE138098T1 (de) Analoga von menschlichem wachstumshormon und ihre verwendung
ATE93527T1 (de) Peptide und deren benutzung.
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
DK0422215T3 (da) Antibakterielle peptider og antimalariapeptider
AR018532A1 (es) Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
SE9402332D0 (sv) Igf-1
NO933628D0 (no) Fremgangsmaate og blanding for behandling av herpes-infeksjoner
IT1243778B (it) Derivati salini dell'acido tauroursodesossicolico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
NO922229L (no) Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties